US FDA grants Orphan Drug Designation to BCMA CAR-T cell therapy co-developed by Innovent Biologics and IASO Bio Read more
Innovent and Eli Lilly announce final clinical results and biomarker analysis of phase-Ib study of Sintilimab injection plus Bevacizumab biosimilar injection Read more